Editas Medicine logo

Editas Medicine

EDIT | NASDAQ
Chart Builder DCF Calculator
$1.87
-$0.30 (-13.82%)
At close: Nov 16, 2026, 4:00 PM ET
$1.90
+$0.03 (+1.60%)
After-hours: Nov 16, 2026, 7:57 PM ET
-13.82%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
55.5
Fundamentals Strong
Market Sentiment Neutral
Moat None
Sector Rank #179/1021 (Top 18%)

Key Statistics

Market Data

Market Cap $288.62M
1D Range
1.86 2.12
52W Range
1.67 3.75

Valuation (TTM)

PE -3.02
PB 3.41
EV/EBITDA -1.55

Valuation (NTM)

Forward PE N/A
Forward PEG 0.06
Price Target $5.50
Loading financial charts...

Profile

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene edi...

Sector Healthcare
Industry Biotechnology
Employees 87
IPO Date Feb 3, 2016
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 9, 2026
EPS
-$0.15
Beat +19.05%
REV
$10.37M
Beat +132.42%
Next Earnings
Mar 8, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$5.50
Upside
+194.12%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.